BG62771B1 - Хетероциклилкарбоксамидни производни, метод за получаването и използването им като терапевтични средства - Google Patents
Хетероциклилкарбоксамидни производни, метод за получаването и използването им като терапевтични средства Download PDFInfo
- Publication number
- BG62771B1 BG62771B1 BG102145A BG10214597A BG62771B1 BG 62771 B1 BG62771 B1 BG 62771B1 BG 102145 A BG102145 A BG 102145A BG 10214597 A BG10214597 A BG 10214597A BG 62771 B1 BG62771 B1 BG 62771B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- methyl
- benzodioxan
- carboxamide
- ylmethyl
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9514380.6A GB9514380D0 (en) | 1995-07-13 | 1995-07-13 | Therapeutic agents |
| PCT/EP1996/002890 WO1997003071A1 (fr) | 1995-07-13 | 1996-07-02 | Derives heterocyclylcarboxamides et leur utilisation en tant qu'agents therapeutiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG102145A BG102145A (en) | 1998-11-30 |
| BG62771B1 true BG62771B1 (bg) | 2000-07-31 |
Family
ID=10777626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG102145A BG62771B1 (bg) | 1995-07-13 | 1997-12-23 | Хетероциклилкарбоксамидни производни, метод за получаването и използването им като терапевтични средства |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5935973A (fr) |
| EP (1) | EP0839145B1 (fr) |
| JP (1) | JPH11508599A (fr) |
| KR (1) | KR19990028918A (fr) |
| CN (1) | CN1071755C (fr) |
| AT (1) | ATE253573T1 (fr) |
| AU (1) | AU708890B2 (fr) |
| BG (1) | BG62771B1 (fr) |
| BR (1) | BR9609506A (fr) |
| CA (1) | CA2223472A1 (fr) |
| CZ (1) | CZ388497A3 (fr) |
| DE (1) | DE69630604T2 (fr) |
| GB (1) | GB9514380D0 (fr) |
| HR (1) | HRP960348A2 (fr) |
| HU (1) | HUP9901485A3 (fr) |
| IL (1) | IL122540A (fr) |
| MX (1) | MX9800084A (fr) |
| NO (1) | NO980129D0 (fr) |
| NZ (1) | NZ313164A (fr) |
| PL (1) | PL324529A1 (fr) |
| RU (1) | RU2169147C2 (fr) |
| SK (1) | SK2498A3 (fr) |
| TR (1) | TR199800041T1 (fr) |
| TW (1) | TW454006B (fr) |
| WO (1) | WO1997003071A1 (fr) |
| ZA (1) | ZA965921B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9811879D0 (en) * | 1998-06-03 | 1998-07-29 | Knoll Ag | Therapeutic agents |
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| UA73981C2 (en) | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
| AU4890301A (en) | 2000-04-17 | 2001-10-30 | Dong Wha Pharmaceutical Industrial Co., Ltd. | 6-methylnicotinamide derivatives as antiviral agents |
| AU2002221744A1 (en) * | 2000-11-14 | 2002-05-27 | Merck Patent Gmbh | Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
| ES2280602T3 (es) * | 2001-07-26 | 2007-09-16 | Merck Patent Gmbh | Uso de 2-(5-(4-fluorofenil)-3-piridilmetilaminometil)-cromano y sus sales fisiologicamente aceptables. |
| PL2256106T3 (pl) | 2003-07-22 | 2015-08-31 | Astex Therapeutics Ltd | Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3) |
| WO2005080394A1 (fr) * | 2004-02-24 | 2005-09-01 | Bioaxone Therapeutique Inc. | Derives de piperidine substitues en position 4 |
| JP4604583B2 (ja) * | 2004-07-20 | 2011-01-05 | ダイソー株式会社 | １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法 |
| CA2594474C (fr) | 2005-01-21 | 2016-03-29 | Astex Therapeutics Limited | Composes pharmaceutiques |
| US20090036435A1 (en) | 2005-01-21 | 2009-02-05 | Astex Therapeutics Limited | Pharmaceutical Compounds |
| TWI457122B (zh) * | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物 |
| CA2722978A1 (fr) * | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulateurs de la neurotransmission de la dopamine |
| BR112014030629B1 (pt) * | 2012-06-11 | 2021-12-21 | Bristol-Myers Squibb Company | Prófármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino) quinazolin -2-il] piridina-3-sulfonamida e composição farmacêutica que os compreende |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8302622D0 (en) * | 1983-01-31 | 1983-03-02 | Celltech Ltd | Immunoassay |
| EP0200960A1 (fr) * | 1985-05-08 | 1986-11-12 | Abbott Laboratories | Immuno-essai à base de la fluorescence polarisée pour l'estriol total |
| JPH05505599A (ja) * | 1990-03-15 | 1993-08-19 | ジ・アップジョン・カンパニー | 治療上有用な複素環インドール化合物類 |
| US5240943A (en) * | 1991-12-19 | 1993-08-31 | G. D. Searle & Co. | Benzopyran class iii antiarrhythmic agents |
| GB9314758D0 (en) * | 1993-07-16 | 1993-08-25 | Wyeth John & Brother Ltd | Heterocyclic derivatives |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| FR2724383B1 (fr) * | 1994-09-13 | 1996-10-18 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique |
-
1995
- 1995-07-13 GB GBGB9514380.6A patent/GB9514380D0/en active Pending
-
1996
- 1996-07-02 MX MX9800084A patent/MX9800084A/es not_active Application Discontinuation
- 1996-07-02 CN CN96195477A patent/CN1071755C/zh not_active Expired - Fee Related
- 1996-07-02 TR TR1998/00041T patent/TR199800041T1/xx unknown
- 1996-07-02 SK SK24-98A patent/SK2498A3/sk unknown
- 1996-07-02 AT AT96924847T patent/ATE253573T1/de not_active IP Right Cessation
- 1996-07-02 PL PL96324529A patent/PL324529A1/xx unknown
- 1996-07-02 DE DE69630604T patent/DE69630604T2/de not_active Expired - Fee Related
- 1996-07-02 KR KR1019980700220A patent/KR19990028918A/ko not_active Application Discontinuation
- 1996-07-02 WO PCT/EP1996/002890 patent/WO1997003071A1/fr not_active Application Discontinuation
- 1996-07-02 HU HU9901485A patent/HUP9901485A3/hu unknown
- 1996-07-02 NZ NZ313164A patent/NZ313164A/xx unknown
- 1996-07-02 EP EP96924847A patent/EP0839145B1/fr not_active Expired - Lifetime
- 1996-07-02 IL IL12254096A patent/IL122540A/en not_active IP Right Cessation
- 1996-07-02 US US08/981,671 patent/US5935973A/en not_active Expired - Lifetime
- 1996-07-02 AU AU65172/96A patent/AU708890B2/en not_active Ceased
- 1996-07-02 JP JP9505471A patent/JPH11508599A/ja not_active Withdrawn
- 1996-07-02 RU RU98102441/04A patent/RU2169147C2/ru active
- 1996-07-02 CZ CZ973884A patent/CZ388497A3/cs unknown
- 1996-07-02 CA CA002223472A patent/CA2223472A1/fr not_active Abandoned
- 1996-07-02 BR BR9609506A patent/BR9609506A/pt unknown
- 1996-07-12 HR HR9514380.6A patent/HRP960348A2/hr not_active Application Discontinuation
- 1996-07-12 ZA ZA9605921A patent/ZA965921B/xx unknown
- 1996-12-19 TW TW085115692A patent/TW454006B/zh not_active IP Right Cessation
-
1997
- 1997-12-23 BG BG102145A patent/BG62771B1/bg unknown
-
1998
- 1998-01-12 NO NO980129A patent/NO980129D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL122540A (en) | 2001-10-31 |
| KR19990028918A (ko) | 1999-04-15 |
| PL324529A1 (en) | 1998-06-08 |
| CN1071755C (zh) | 2001-09-26 |
| US5935973A (en) | 1999-08-10 |
| EP0839145B1 (fr) | 2003-11-05 |
| GB9514380D0 (en) | 1995-09-13 |
| SK2498A3 (en) | 1998-09-09 |
| BG102145A (en) | 1998-11-30 |
| AU708890B2 (en) | 1999-08-12 |
| ZA965921B (en) | 1998-01-12 |
| RU2169147C2 (ru) | 2001-06-20 |
| HUP9901485A2 (en) | 2000-07-28 |
| NO980129L (no) | 1998-01-12 |
| WO1997003071A1 (fr) | 1997-01-30 |
| CZ388497A3 (cs) | 1998-06-17 |
| TW454006B (en) | 2001-09-11 |
| DE69630604D1 (de) | 2003-12-11 |
| IL122540A0 (en) | 1998-06-15 |
| CA2223472A1 (fr) | 1997-01-30 |
| HRP960348A2 (en) | 1998-04-30 |
| EP0839145A1 (fr) | 1998-05-06 |
| HUP9901485A3 (en) | 2001-03-28 |
| DE69630604T2 (de) | 2004-09-23 |
| JPH11508599A (ja) | 1999-07-27 |
| AU6517296A (en) | 1997-02-10 |
| BR9609506A (pt) | 1999-06-01 |
| TR199800041T1 (xx) | 1998-05-21 |
| NZ313164A (en) | 1999-07-29 |
| CN1190967A (zh) | 1998-08-19 |
| MX9800084A (es) | 1998-03-29 |
| NO980129D0 (no) | 1998-01-12 |
| ATE253573T1 (de) | 2003-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6107310A (en) | Heteroarylcarboxamide derivatives for treating CNS disorders | |
| BG62771B1 (bg) | Хетероциклилкарбоксамидни производни, метод за получаването и използването им като терапевтични средства | |
| US5100902A (en) | 1,2-benzisoxazole compounds | |
| KR100325964B1 (ko) | 치료제로서의 이환식 방향족 화합물 | |
| JPH0678315B2 (ja) | 新規なベンゾピリド‐ピペリジン、ピペリジリデンおよびピペラジン化合物、組成物、製造法および利用法 | |
| AU2003281194A1 (en) | Mchir antagonists | |
| JP2001515485A (ja) | ジオキシノ誘導体および治療薬としてのその使用 | |
| IL109234A (en) | History of indole, their preparation and pharmaceutical preparations containing them | |
| US5296478A (en) | 1-substituted oxindoles as cognition enhancers | |
| EP0288640B1 (fr) | 6,11-Dihydro-11-(4-pipéridylidène)-5H-benzo[5,6]cyclohepta[1,2-b]-pyrridines et compositions ainsi que procédés d'utilisation | |
| JP2001522366A (ja) | ドーパミンｄ▲上３▼受容体のモジュレーターとしての置換テトラヒドロイソキノリン誘導体 | |
| EP0325964A1 (fr) | Composés aminométhyliques de chromane et thiochromane | |
| EP0441517A2 (fr) | Amines tricycliques comme inhibiteurs de cholinestérase | |
| HUT54151A (en) | Process fopr producing new (r)-(-)-3-quinuclidinone derivatives and pharmaceutical compositions comprising such compounds | |
| US6136825A (en) | Sulfonamide compounds having 5-HT receptor activity | |
| US6562809B1 (en) | 3-bicycloindole compounds | |
| HRP970020A2 (en) | Therapeutic agents | |
| US5428043A (en) | Tricyclic-cyclic amines as novel cholinesterase inhibitors | |
| CZ293010B6 (cs) | Naftydrinový derivát, farmaceutická kompozice s jeho obsahem, použití a způsob přípravy tohoto derivátu | |
| CN117126146A (zh) | 阿片受体激动剂及其制备方法和用途 | |
| KR20050016991A (ko) | Ｍｃｈｉｒ 길항제 | |
| MXPA06000089A (en) | Tricyclic delta opioid modulators |